Skip to main content
UniHealth

Doctor search

Anjali T Sibley, MD

Hematology/Oncology · Stanford

NPI 1750580080

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
9
1 carrier
Offices
2

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

9 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sibley’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026

California Medical Board record

Licence C143846 · Current

Licensed to practise in California · since 2016 · expires 2027-10-31 · University of Tennessee College of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

State licence records

1 licence

  • Tennessee 47748Medical Doctor · since 2011 · expires 2017-10-31Specialty on the licence: Hematology
    ExpiredNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

School, training and certification

4 placements

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Education

  • University of Tennessee · MDMEMPHIS, TN · 2003Medical school

Residency and fellowship

  • University of ArkansasLITTLE ROCK, AR · 2007–2010
  • Mt. Auburn HospitalCAMBRIDGE, MA · 2005–2007
  • Mt. Auburn HospitalCAMBRIDGE, MA · 2004–2005
  • Baylor InstituteDALLAS, TX · 2003–2004

Hospitals they work in

4 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
  • Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Alta Bates Summit Medical Center
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths130.09 (87.72 to 172.46) · 109 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.274BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.227BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1 (0.06 to 1.94) · 1,209 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.88 (0.6 to 1.16)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2 · 89 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.9 · 105 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.8 · 270 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.9 · 447 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths13.7 · 341 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths11.2 · 381 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.6 · 2,811 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.31) · 7,167 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.21 (0.02 to 0.4) · 7,659 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.93 (0.92 to 4.94) · 1,668 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.25 (0 to 2.75) · 580 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.67 (1.19 to 4.15) · 1,446 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.17 (0.33 to 12.02) · 633 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths8.11 (4.67 to 11.55) · 619 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.15 to 3.07) · 309 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.39 (0 to 0.96) · 6,085 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.8 · 217 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.724No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.425No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.716No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits12.7 · 416 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.6 · 606 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-30.4 · 359 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-31.8 · 555 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-14.4 · 358 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16 · 382 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.1 (3.2 to 8.2) · 25 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.8 (7.3 to 16) · 25 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits4.5 · 232 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.9 · 56 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 152 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits14.8 (11.1 to 20) · 251 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.2 (0.9 to 1.5) · 579 casesNo differentJan 2024 – Dec 2024

What patients said (535 patients answered, 18% of those asked)

Patient survey stars by topic at Alta Bates Summit Medical Center
Cleanliness4
Nurse communication3
Doctor communication4
Communication about medicines2
Discharge information3
Overall hospital rating4
Quietness3
Recommend hospital5
Share of patients giving the best answer at Alta Bates Summit Medical Center
Room was "always" clean73%
Nurses "always" communicated well75%
Doctors "always" communicated well81%
Staff "always" explained58%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully79%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)75%
Staff "always" explained new medications73%
Nurses "always" explained things so they could understand69%
Nurses "always" listened carefully72%
Nurses "always" treated them with courtesy and respect85%
"Always" quiet at night54%
"YES", patients would definitely recommend the hospital78%
Staff "always" explained possible side effects43%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp

Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Alta Bates Summit Medical Center - Alta Bates Camp
Clostridium Difficile (C.Diff)Infections0.298BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.18 (0.16 to 2.2) · 730 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.87 (0.51 to 1.23)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths188.12 (132.31 to 243.94) · 50 casesNo differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths6.8 · 50 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.8 · 41 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.4 · 189 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths12.6 · 184 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 103 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.9 · 1,585 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.18 (0 to 0.4) · 3,929 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.31 (0.11 to 0.51) · 3,954 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.15 (0.95 to 5.36) · 754 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.62 (0 to 3.33) · 325 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.99 (0.39 to 3.59) · 717 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths10.85 (2.27 to 19.44) · 326 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.79 (1.08 to 8.49) · 302 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.68 (0.19 to 3.18) · 184 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.17 (0 to 0.88) · 3,240 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.4 · 161 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.207No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.48No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.785No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.4 · 243 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-58.2 · 194 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-12.3 · 177 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 209 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.4 (3.8 to 7.5) · 215 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.2 (9.4 to 15.5) · 215 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits4.8 · 150 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.2 · 81 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.4 (10 to 18.1) · 315 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.6 to 1.2) · 137 casesNo differentJan 2024 – Dec 2024

What patients said (449 patients answered, 15% of those asked)

Patient survey stars by topic at Alta Bates Summit Medical Center - Alta Bates Camp
Cleanliness2
Nurse communication2
Doctor communication2
Communication about medicines2
Discharge information2
Overall hospital rating2
Quietness2
Recommend hospital3
Share of patients giving the best answer at Alta Bates Summit Medical Center - Alta Bates Camp
Room was "always" clean62%
Nurses "always" communicated well72%
Doctors "always" communicated well75%
Staff "always" explained53%
Yes, staff "did" give patients this information82%
Yes, staff "did" give patients information about help after discharge82%
Doctors "always" explained things so they could understand68%
Doctors "always" listened carefully73%
Doctors "always" treated them with courtesy and respect83%
Patients who gave a rating of "9" or "10" (high)58%
Staff "always" explained new medications67%
Nurses "always" explained things so they could understand67%
Nurses "always" listened carefully66%
Nurses "always" treated them with courtesy and respect81%
"Always" quiet at night49%
"YES", patients would definitely recommend the hospital67%
Staff "always" explained possible side effects38%
Yes, staff "did" give patients information about possible symptoms83%
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$149,759

Medicare paid this office $149,759 for 382 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)347$83,271$93
Long return visit (40+ min)111$53,823$141
New patient visit (60+ min)44$8,063$183
New patient visit (45+ min)26$3,003$111
Short return visit (20+ min)19$1,500$71

Who their Medicare patients are

382 Original Medicare patients in 2024. Average age 76 · Under 65 5% · 85 and older 17% · Women 56% · Also on Medicaid 12% · Health risk score 1.79. At or below the middle of the specialty; the typical hematology-oncology clinician is at 2.04.

Conditions among them: High blood pressure 69% · Cancer 37% · Chronic kidney disease 33% · Diabetes 28% · Coronary heart disease 27% · Atrial fibrillation 19% · Depression 19% · Heart failure 17% · COPD 13% · Stroke 10% · Dementia 5%.

The office billed $602,792, Medicare allowed $201,522 and paid $149,759; for 1,376 services of 8 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20243821,376761.79$602,792$149,759
20233391,268761.68$461,530$119,243
20222961,296761.72$382,765$85,782
2021233857741.50$213,805$64,921
202048608703.00$57,892$13,328
20192131693.61$30,743$7,818
201580457702.11$97,553$21,267
201482459702.30$96,611$22,424
201397386682.16$83,264$20,713

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 5 services

Original Medicare services billed in 2023
Return visit (30+ min)298$66,379$83
Long return visit (40+ min)111$38,465$126
New patient visit (60+ min)47$7,545$161
New patient visit (45+ min)35$4,088$117
Short return visit (20+ min)66$2,437$33

2022: 6 services

Original Medicare services billed in 2022
Short return visit (20+ min)267$44,575$54
Return visit (30+ min)147$29,493$86
New patient visit (45+ min)54$4,987$92
New patient visit (60+ min)23$3,801$165
New patient visit (30+ min)11$596$54
Short return visit14$479$32

2021: 7 services

Original Medicare services billed in 2021
Short return visit (20+ min)193$30,802$57
Return visit (30+ min)81$12,113$87
New patient visit (60+ min)58$9,385$162
New patient visit (45+ min)79$9,376$119
Long return visit (40+ min)13$1,630$125
New patient visit (30+ min)16$1,217$76
Short return visit11$370$31

2020: 1 service

Original Medicare services billed in 2020
Short return visit (20+ min)19$2,193$48

2015: 4 services

Original Medicare services billed in 2015
Return visit (30+ min)34$9,344$55
Short return visit (20+ min)67$8,288$36
New patient visit (60+ min)11$1,146$104
Short return visit13$248$15

2014: 4 services

Original Medicare services billed in 2014
Return visit (30+ min)43$10,436$55
Short return visit (20+ min)57$7,248$36
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes13$890$52
Short return visit12$264$19

2013: 5 services

Original Medicare services billed in 2013
Return visit (30+ min)40$8,338$56
Short return visit (20+ min)49$4,354$35
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes18$1,537$51
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes11$1,531$77
New patient visit (60+ min)12$1,350$112

Medicaid work

$156,255 in 2020

Medicaid paid $156,255 for 3,612 billed services this clinician did in 2020, up to 66 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2020
Clinic visit/encounter, all-inclusive404$132,135
Service300$24,120
Service115$0
COLLECTION VENOUS BLOOD VENIPUNCTURE187$0
COMPREHENSIVE METABOLIC PANEL79$0
Measurement of vitamin D 25 hydroxy14$0
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count269$0
Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug96$0
Short return visit99$0
Short return visit (20+ min)264$0
Return visit (30+ min)56$0
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion258$0
Medicaid work by year
20203,6121966$156,255
20196,9002177$353,764
20182,8151252$271,659
See the largest Medicaid services in earlier years

2019

Largest Medicaid services in 2019
Clinic visit/encounter, all-inclusive847$276,810
Service940$76,954
Service106$0
Service186$0
COLLECTION VENOUS BLOOD VENIPUNCTURE574$0
Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520)56$0
COMPREHENSIVE METABOLIC PANEL259$0
HEPATIC FUNCTION PANEL82$0
VITAMIN B-1216$0
Measurement of iron16$0
Measurement of transferrin16$0
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count634$0

2018

Largest Medicaid services in 2018
Clinic visit/encounter, all-inclusive686$222,271
Service604$49,388
Service17$0
COLLECTION VENOUS BLOOD VENIPUNCTURE279$0
COMPREHENSIVE METABOLIC PANEL82$0
HEPATIC FUNCTION PANEL18$0
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count305$0
Short return visit (20+ min)262$0
Return visit (30+ min)236$0
Injection, heparin sodium, (heparin lock flush), per 10 units16$0
Unclassified drugs253$0
Infusion, normal saline solution , 1000 cc57$0

Drugs they prescribed that Part D paid

$1,515,791

Pharmacies billed $1,515,791 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 5% of their Part D prescriptions (45 of 919) in 2024. At or below the middle of the specialty; the typical hematology-oncology clinician is at 5%. Long-acting opioids: 27% of their opioid prescriptions.

674 generic and 245 brand-name prescriptions · $1,515,791 in drug cost · 42 antibiotic prescriptions to 31 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Eliquis115$104,661$910
Xarelto12$20,503$1,709
Megestrol Acetate25$1,988$80
Ondansetron32$1,162$36
Albuterol Sulfate Hfa20$940$47
See all 23 drugs
Every Part D drug this clinician prescribed
Eliquis115$104,661$910
Xarelto12$20,503$1,709
Megestrol Acetate25$1,988$80
Ondansetron32$1,162$36
Albuterol Sulfate Hfa20$940$47
Exemestane24$889$37
Dexamethasone36$648$18
Anastrozole24$614$26
Letrozole17$531$31
Prochlorperazine Maleate26$443$17
Hydroxyurea16$342$21
Acyclovir13$319$25
Levothyroxine17$269$16
Gabapentin15$267$18
Ondansetron Odt11$260$24
Doxycycline Hyclate20$201$10
Pantoprazole11$182$17
Famotidine18$165$9
Furosemide23$163$7
Folic Acid20$120$6
Prednisone16$84$5
Tramadol11$35$3
Lorazepam13$33$3

Year by year

Part D prescribing by year
20249192105% (45)27%$1,515,791
20238961743% (25)None$1,246,059
20221,0321665% (50)None$955,481
20214991195% (26)None$440,381
20203325914% (47)None$217,435
20194397019% (81)21%$449,342
20183336014% (46)None$78,170
20174224011% (45)None$41,613
20167224NoneNone$4,933
20155976415% (92)None$360,400
20145636122% (125)None$144,276
20132564732% (83)None$16,083

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 21 drugs

Part D drugs prescribed in 2023
Ibrance11$177,144$16,104
Brukinsa11$169,681$15,426
Eliquis97$87,209$899
Xarelto12$21,183$1,765
Exemestane12$2,857$238
Megestrol Acetate14$1,554$111
Anastrozole31$1,044$34
Hydroxyurea20$788$39
Ondansetron41$648$16
Dexamethasone34$536$16
Gabapentin35$514$15
Albuterol Sulfate Hfa16$449$28
Levothyroxine18$403$22
Prochlorperazine Maleate24$328$14
Pantoprazole15$317$21
Letrozole13$309$24
Prednisone34$271$8
Fluoxetine11$168$15
Furosemide29$163$6
Doxycycline Hyclate16$124$8
Lorazepam14$68$5

2022: 24 drugs

Part D drugs prescribed in 2022
Eliquis94$73,719$784
Xarelto12$17,881$1,490
Abiraterone Acetate16$17,813$1,113
Creon11$5,860$533
Anastrozole55$1,923$35
Megestrol Acetate20$1,204$60
Ondansetron48$1,030$21
Albuterol Sulfate Hfa17$944$56
Pantoprazole17$873$51
Morphine Sulfate Er11$601$55
Hydroxyurea20$517$26
Gabapentin29$463$16
Letrozole19$460$24
Levothyroxine23$452$20
Prochlorperazine Maleate33$451$14
Prednisone49$422$9
Famotidine32$333$10
Dexamethasone19$320$17
Hydrocodone-Acetaminophen12$181$15
Furosemide44$155$4
Tramadol16$108$7
Omeprazole11$92$8
Olanzapine16$82$5
Lorazepam14$34$2

2021: 12 drugs

Part D drugs prescribed in 2021
Eliquis32$22,483$703
Anastrozole25$1,221$49
Megestrol Acetate20$806$40
Ondansetron26$640$25
Levothyroxine16$359$22
Pantoprazole11$269$24
Gabapentin11$234$21
Famotidine14$196$14
Prochlorperazine Maleate12$156$13
Tramadol12$48$4
Lorazepam13$35$3
Furosemide13$31$2

2020: 6 drugs

Part D drugs prescribed in 2020
Eliquis11$6,907$628
Anastrozole21$639$30
Ondansetron21$469$22
Hydrocodone-Acetaminophen20$401$20
Promethazine14$88$6
Tramadol12$77$6

2019: 9 drugs

Part D drugs prescribed in 2019
Hydrocodone-Acetaminophen41$908$22
Megestrol Acetate11$804$73
Anastrozole28$478$17
Tramadol27$172$6
Dexamethasone11$171$16
Mupirocin11$152$14
Loperamide11$145$13
Prednisone12$89$7
Promethazine11$71$6

2018: 6 drugs

Part D drugs prescribed in 2018
Ondansetron37$540$15
Megestrol Acetate11$520$47
Hydrocodone-Acetaminophen23$511$22
Promethazine24$172$7
Dexamethasone12$149$12
Amlodipine Besylate11$93$8

2017: 9 drugs

Part D drugs prescribed in 2017
Lantus14$7,224$516
Ventolin Hfa12$963$80
Megestrol Acetate11$543$49
Cyclobenzaprine11$417$38
Hydrocodone-Acetaminophen28$250$9
Atorvastatin13$203$16
Amlodipine Besylate22$100$5
Omeprazole12$78$6
Hydrochlorothiazide12$60$5

2016: 1 drug

Part D drugs prescribed in 2016
Anastrozole11$123$11

2015: 17 drugs

Part D drugs prescribed in 2015
Enoxaparin11$21,289$1,935
Morphine Sulfate Er12$1,498$125
Oxycodone40$1,002$25
Ondansetron35$783$22
Lidocaine-Prilocaine20$690$35
Megestrol Acetate13$393$30
Gabapentin18$315$17
Levothyroxine14$299$21
Anastrozole17$261$15
Zolpidem14$194$14
Dexamethasone27$156$6
Levofloxacin20$126$6
Tramadol13$84$6
Dicyclomine15$68$5
Alprazolam24$66$3
Triamterene-Hydrochlorothiazid12$58$5
Furosemide15$20$1

2014: 13 drugs

Part D drugs prescribed in 2014
Dronabinol14$3,736$267
Oxycodone54$1,469$27
Ondansetron28$590$21
Levofloxacin16$364$23
Lidocaine-Prilocaine13$359$28
Dexamethasone53$281$5
Sucralfate13$254$20
Pantoprazole21$245$12
Tramadol30$172$6
Morphine Sulfate11$152$14
Promethazine13$110$8
Zolpidem12$47$4
Alprazolam15$39$3

2013: 6 drugs

Part D drugs prescribed in 2013
Morphine Sulfate Er12$1,070$89
Morphine Sulfate19$404$21
Ondansetron18$396$22
Oxycodone15$229$15
Tramadol22$153$7
Dexamethasone16$114$7

Money from drug and device companies

$487 in 2025

Industry payments by year
20251319None$487
202489None$234
2023710None$230
202246None$146
202126None$167
202044None$92

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
CelgeneReblozyl$150
5 payments
  • Meals for Reblozyl · 2025-10-24 · $28
  • Meals for Reblozyl · 2025-08-19 · $31
  • Meals for Reblozyl · 2025-06-25 · $30
  • Meals for Opdivo · 2025-04-04 · $35
  • Meals for Reblozyl · 2025-03-11 · $26
Array BiopharmaLorbrena$59
2 payments
  • Meals for Braftovi · 2025-08-15 · $26
  • Meals for Lorbrena · 2025-06-13 · $33
Astellas Pharma USVyloy$37
2 payments
  • Meals for Vyloy · 2025-10-31 · $19
  • Meals for Vyloy · 2025-03-28 · $18
Janssen BiotechRybrevant$34
1 payment
  • Meals for Rybrevant · 2025-05-21 · $34
PfizerBosulif$29
1 payment
  • Meals for Bosulif · 2025-01-13 · $29
Kyowa KirinPoteligeo$27
1 payment
  • Meals for Poteligeo · 2025-01-29 · $27
See all 19 published payments
Every published payment
Takeda Pharmaceuticals U.S.A.Meals · 2025-11-06Iclusig$25
Astellas Pharma USMeals · 2025-10-31Vyloy$19
CelgeneMeals · 2025-10-24Reblozyl$28
CelgeneMeals · 2025-08-19Reblozyl$31
Array BiopharmaMeals · 2025-08-15Braftovi$26
Gilead SciencesMeals · 2025-07-30Trodelvy$18
E.R. Squibb & Sons L.L.C.Meals · 2025-07-15Opdivo$21
CelgeneMeals · 2025-06-25Reblozyl$30
Array BiopharmaMeals · 2025-06-13Lorbrena$33
GlaxoSmithKlineMeals · 2025-06-04Ojjaara$20
Janssen BiotechMeals · 2025-05-21Rybrevant$34
AstraZeneca Pharmaceuticals LPEducation · 2025-04-21None$23
SpringWorks TherapeuticsMeals · 2025-04-15Ogsiveo$20
CelgeneMeals · 2025-04-04Opdivo$35
Astellas Pharma USMeals · 2025-03-28Vyloy$18
CelgeneMeals · 2025-03-11Reblozyl$26
EisaiMeals · 2025-02-19Lenvima$21
Kyowa KirinMeals · 2025-01-29Poteligeo$27
PfizerMeals · 2025-01-13Bosulif$29
See earlier years (2024, 2023, 2022, 2021, 2020)

2024: $234

Payments by company in 2024
AbbvieImbruvica$45
2 payments
  • Meals for Imbruvica · 2024-10-14 · $20
  • Meals for Imbruvica · 2024-09-17 · $25
GlaxoSmithKlineJemperli$32
1 payment
  • Meals for Jemperli · 2024-04-19 · $32
CelgeneReblozyl$31
1 payment
  • Meals for Reblozyl · 2024-06-11 · $31
Merck Sharp & DohmeKeytruda$27
1 payment
  • Meals for Keytruda · 2024-10-16 · $27
EisaiLenvima$27
1 payment
  • Meals for Lenvima · 2024-08-12 · $27
Array BiopharmaXalkori$26
1 payment
  • Meals for Xalkori · 2024-12-18 · $26
Novartis PharmaceuticalsFabhalta$25
1 payment
  • Meals for Fabhalta · 2024-11-06 · $25
SpringWorks TherapeuticsOgsiveo$21
1 payment
  • Meals for Ogsiveo · 2024-09-19 · $21

2023: $230

Payments by company in 2023
PfizerXtandi$56
3 payments
  • Meals for Xtandi · 2023-10-26 · $20
  • Meals for Besponsa · 2023-10-13 · $18
  • Meals for Xtandi · 2023-04-18 · $18
CelgeneReblozyl$54
2 payments
  • Meals · 2023-03-29 · $26
  • Meals for Reblozyl · 2023-03-10 · $27
Jazz PharmaceuticalsZepzelca$26
1 payment
  • Meals for Zepzelca · 2023-05-24 · $26
Janssen BiotechImbruvica$25
1 payment
  • Meals for Imbruvica · 2023-04-17 · $25
Takeda Pharmaceuticals U.S.A.Ninlaro$24
1 payment
  • Meals for Ninlaro · 2023-03-20 · $24
EisaiLenvima$23
1 payment
  • Meals for Lenvima · 2023-08-22 · $23
Pharmacyclics LLC An AbbVieImbruvica$22
1 payment
  • Meals for Imbruvica · 2023-04-26 · $22

2022: $146

Payments by company in 2022
Daiichi SankyoInjectafer$50
2 payments
  • Meals for Injectafer · 2022-12-06 · $28
  • Meals for Injectafer · 2022-10-21 · $22
Intuitive SurgicalDa Vinci Surgical System$48
2 payments
  • Meals for Da Vinci Surgical System · 2022-10-18 · $26
  • Meals for Da Vinci Surgical System · 2022-10-18 · $21
Janssen BiotechImbruvica$24
1 payment
  • Meals for Imbruvica · 2022-12-19 · $24
Jazz PharmaceuticalsZepzelca$23
1 payment
  • Meals for Zepzelca · 2022-07-27 · $23

2021: $167

Payments by company in 2021
Lilly USANone$96
1 payment
  • Education · 2021-05-22 · $96
PfizerLorbrena$71
5 payments
  • Education for Lorbrena · 2021-11-18 · $18
  • Education for Lorbrena · 2021-11-18 · $16
  • Education for Lorbrena · 2021-11-18 · $12
  • Education for Lorbrena · 2021-08-13 · $12
  • Education for Inlyta · 2021-03-24 · $13

2020: $92

Payments by company in 2020
Intuitive SurgicalDa Vinci Surgical System$36
1 payment
  • Meals for Da Vinci Surgical System · 2020-03-04 · $36
Janssen BiotechDarzalex$25
1 payment
  • Meals for Darzalex · 2020-11-06 · $25
SeagenPadcev$18
1 payment
  • Meals for Padcev · 2020-10-07 · $18
PfizerInlyta$13
1 payment
  • Education for Inlyta · 2020-10-06 · $13

Professional record

NPI
1750580080
Licence
CA C143846, NH 15046, TN MD47748California C143846: Current · expires 2027-10-31Tennessee 47748: Expired
Trained
University of Tennessee, Hsc, College of Medicine, 2003
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Medical oncology (207RX0202X); Internal medicine (207R00000X); Federal specialty code 207RH0000X (207RH0000X); Federal specialty code 207RH0003X (207RH0003X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2007-07-17
NPI last updated
2024-04-16
NPI record certified
2024-04-16

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 5800 Hollis St, Emeryville, CA, 94608